Kelderman Kim 4

What Happened
Kim Kelderman, CEO of Bio-Techne (TECH), exercised options to acquire 36,500 shares on 2026-04-14. On the same date she surrendered 32,088 shares to satisfy tax withholding obligations, a disposition valued at $1,882,282 (32,088 shares × $58.66). Net of the withholding, Kelderman received 4,412 shares.

Key Details

• Transaction date: 2026-04-14; Form 4 filed 2026-04-16 (timely).
• Exercise reported as derivative conversion (code M) for 36,500 shares at $0.00 (reported exercise price).
• Tax withholding reported (code F): 32,088 shares disposed at $58.66 per share for $1,882,282.
• Net new shares retained from the exercise: 4,412 shares (36,500 acquired − 32,088 withheld).
• Footnote indicates the options were fully exercisable (Footnote F1).
• Filing does not disclose total shares held by Kelderman after the transaction in the details you provided.

Context
This appears to be a routine option exercise with shares withheld to pay taxes (a common practice), rather than an open-market sale intended as a liquidity or investment signal. Code reference: M = option exercise/conversion; F = payment of exercise price or tax liability.